focus -WSS

focus

author：entertainment 2025-09-30 01:02:48 - browse：9741

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Amazon on where the company's health care bets are headed next

WSS

Humana sues Biden admin over Medicare Advantage audit rule

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

How to protect patients from sexual assault

3 killed, 8 injured in late

Advances in CAR

Amazon on where the company's health care bets are headed next

focus

focus

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Greece's new parliament sworn in following conservative party's election victory

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

1 dead, 9 hurt in July 4th fireworks explosion

As demand for Covid shots wanes, Moderna seeks its next success

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

In age of alternative facts, a scholarly course on calling out crap

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Guidelines to prevent youth baseball injuries need more muscle

How to protect patients from sexual assault

focus

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

How to protect patients from sexual assault

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Ethical issues complicate the benefits of medical crowdfunding

How to protect patients from sexual assault

focus

knowledge

focus

focus